Q2 2020 Urogen Pharma Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the UroGen Pharma Second Quarter 2020 Financial Results and Business Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today to Peter Pfreundschuh, CFO. Thank you. Please go ahead.
Thank you, operator. Good morning, everyone, and welcome to UroGen Pharma's Second Quarter 2020 Financial Results and Business Update Conference Call. Earlier this morning, we issued a press release providing an overview of our recent corporate highlights and financial results for the quarter ended June 30, 2020. The press release can be accessed on the Investors portion of our website at investors.urogen.com.
Joining me on the call today are Liz Barrett, President and Chief Executive Officer; Dr. Mark Schoenberg, Chief Medical Officer; and Jeff Bova, Chief Commercial Officer. Please note that we are conducting our call today from different locations, so we appreciate your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |